SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-030519
Filing Date
2024-03-04
Accepted
2024-03-04 17:22:12
Documents
5
Effectiveness Date
2024-03-04

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm247662d1_s8.htm S-8 40831
2 EXHIBIT 5.1 tm247662d1_ex5-1.htm EX-5.1 9463
3 EXHIBIT 23.2 tm247662d1_ex23-2.htm EX-23.2 1733
4 EX-FILING FEES tm247662d1_ex-filingfees.htm EX-FILING FEES 9645
5 GRAPHIC tm247662d1_ex5-1img001.jpg GRAPHIC 25539
  Complete submission text file 0001104659-24-030519.txt   98127
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277637 | Film No.: 24715906
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)